News

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Adicet Bio, Inc. (ACET) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates

Investors might want to bet on Kemper (KMPR), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

BankFinancial (BFIN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Priority Technology (PRTH) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Investors might want to bet on Scor SE (SCRYY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell

Astronics Corporation (ATRO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even

Investors might want to bet on Palantir Technologies Inc. (PLTR), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces

Investors might want to bet on Novozymes A/S (NVZMY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which

The Carlyle Group Inc. CG reported first-quarter 2025 post-tax distributable earnings per share of $1.14, which topped the Zacks Consensus Estimate of 97 cents. The figure compared favorably with

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 15 cents in first-quarter 2025, narrower than the year-ago adjusted loss of 26 cents

Itau Unibanco Holding S.A. ITUB reported recurring managerial results of R$10.5 billion ($1.83 billion) for the first quarter of 2025, which increased 5% year over year.

Higher revenues and an

Tapestry, Inc. TPR reported impressive third-quarter fiscal 2025 results that exceeded the Zacks Consensus Estimate for revenues and earnings.  Also, the top and bottom lines increased year over

India’s stock market experienced sharp declines this week as geopolitical tensions between the country and Pakistan intensified. The Nifty 50 index fell below the 24,000 mark, while the BSE Sensex

HubSpot, Inc. HUBS reported impressive first-quarter 2025 results, with both the adjusted earnings and revenues beating the respective Zacks Consensus Estimate.

The software-as-a-service vendor

Akamai Technologies, Inc. AKAM reported strong first-quarter 2025 results, with both the adjusted earnings and revenues surpassing the Zacks Consensus Estimate. The company reported a top-line

Maximus, Inc. MMS reported better-than-expected second-quarter fiscal 2025 results.

Quarterly adjusted earnings of $2.01 per share beat the Zacks Consensus Estimate by 46.7% and increased 28% year

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your